What is mean corpuscular hemoglobin concentration (MCHC) and what does a low MCHC indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is MCHC and What Does a Low MCHC Mean?

MCHC (Mean Corpuscular Hemoglobin Concentration) measures the concentration of hemoglobin within a given volume of packed red blood cells, and a low MCHC indicates hypochromia—typically signaling iron deficiency, though it can also occur in thalassemia, anemia of chronic disease, or sideroblastic anemia.

Understanding MCHC

MCHC is one of the red blood cell indices automatically reported in a complete blood count (CBC). It represents the average hemoglobin concentration per red blood cell and is expressed in g/dL or g/L 1.

Normal MCHC values typically range from 32-36 g/dL. Values significantly below this range indicate that red blood cells contain less hemoglobin than normal—a condition called hypochromia 1.

What Low MCHC Indicates

Primary Causes of Low MCHC:

  • Iron deficiency anemia (most common cause) 2, 1
  • Thalassemia (especially when MCV is disproportionately low relative to anemia severity) 1
  • Anemia of chronic disease 2, 3
  • Sideroblastic anemia 2

Clinical Significance:

Low MCHC reflects iron-restricted erythropoiesis—meaning red blood cells are being produced without adequate hemoglobin content 1. This occurs in both absolute iron deficiency (depleted iron stores) and functional iron deficiency (adequate stores but impaired iron utilization due to inflammation) 3.

Diagnostic Approach When MCHC is Low

When you encounter a low MCHC, follow this systematic evaluation:

Step 1: Confirm with Additional Red Cell Indices

  • Check MCV (mean corpuscular volume): Low MCHC typically accompanies microcytosis (MCV <80 fL) in iron deficiency 2, 1
  • Check MCH (mean corpuscular hemoglobin): MCH may be more sensitive than MCV for detecting iron deficiency and is less affected by storage conditions 1
  • Check RDW (red cell distribution width): Elevated RDW suggests iron deficiency, especially when microcytosis and macrocytosis coexist 3

Step 2: Obtain Iron Studies

The minimum workup must include 1:

  • Serum ferritin (most specific test for iron deficiency)
    • <15 μg/L: Highly specific for iron deficiency (specificity 0.99)
    • <30 μg/L: Generally indicates low iron stores
    • <45 μg/L: Optimal cutoff balancing sensitivity and specificity (0.92)
    • 150 μg/L: Iron deficiency unlikely even with inflammation

  • Transferrin saturation (TSAT)
    • <20%: Indicates iron-restricted erythropoiesis
    • Robust across inflammatory states including heart failure
  • C-reactive protein (CRP)
    • 10 mg/L: Suggests functional iron deficiency when ferritin is equivocal (30-100 μg/L)

Step 3: Distinguish Between Iron Deficiency Types

Absolute Iron Deficiency 2, 4:

  • Ferritin <30 μg/L
  • TSAT <15%
  • Low or absent iron stores

Functional Iron Deficiency 4, 3:

  • Ferritin 30-300 μg/L (or up to 300 μg/L in heart failure patients)
  • TSAT <20%
  • Elevated CRP
  • Iron present but sequestered due to inflammation

Step 4: Rule Out Other Causes

If iron studies are normal or equivocal 1:

  • Hemoglobin electrophoresis: Essential to exclude thalassemia, particularly in patients with appropriate ethnic background and microcytosis disproportionate to anemia severity
  • Vitamin B12 and folate levels: Combined deficiencies can mask each other (B12/folate deficiency causes macrocytosis, iron deficiency causes microcytosis, resulting in normal MCV but high RDW) 4
  • Reticulocyte count: Low reticulocyte index suggests decreased RBC production; high suggests blood loss or hemolysis 2

Important Clinical Caveats

MCHC Limitations:

  • MCHC is less reliable in certain conditions: It may remain normal in mild iron deficiency and early thalassemia 5
  • Not useful for assessing iron status in heart failure: Mean corpuscular volume, MCH, and MCHC are unreliable markers in HF patients 6
  • Inflammation can confound interpretation: Ferritin acts as an acute phase reactant and may appear falsely normal despite true iron deficiency 1

Prognostic Implications:

Recent evidence suggests low MCHC independently predicts worse outcomes in several conditions:

  • Increased mortality in hypertensive patients 7
  • Higher risk of cardiovascular events in dialysis patients 8
  • Predictor of COPD exacerbations 9
  • Associated with mortality in ICU cancer patients 10

Therapeutic Response as Diagnostic Tool:

A hemoglobin rise ≥10 g/L within 2 weeks of iron therapy strongly suggests absolute iron deficiency, even when iron studies are equivocal 1. This therapeutic trial can be diagnostically valuable when laboratory results are unclear.

When to Investigate Further

Any level of anemia with confirmed iron deficiency warrants investigation for underlying causes, particularly gastrointestinal blood loss or malabsorption 1, 11, 1. The case for investigation strengthens with more severe anemia, as serious pathology (including malignancy) becomes more likely 1.

In menstruating women, dietary insufficiency and menstrual blood loss are common causes. In adult men and postmenopausal women, gastrointestinal blood loss is the most common cause and requires endoscopic evaluation 11.

References

Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Research

[Must we teach, today, the MCHC (Mean Corpuscular Haemoglobin Concentration)? (author's transl)].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1980

Related Questions

What does a mean corpuscular hemoglobin concentration (MCHC) of 30.2 g/dL indicate and how should it be evaluated and managed?
What are the clinical indications for a low mean corpuscular hemoglobin concentration (MCHC) of 32.7 g/dL?
What is the interpretation of a hemoglobin of 11.2 g/dL, mean corpuscular hemoglobin (MCH) of 25.8 pg, and mean corpuscular hemoglobin concentration (MCHC) of 30.8 g/dL?
What is the significance of a hemoglobin of 11.8 g/dL and an MCHC of 31.1 g/dL, and what evaluation and management steps are recommended?
What are the possible causes and clinical significance of a high white blood cell count with low monocytes and low mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC)?
In a patient taking simvastatin 40 mg, how much can the dose be increased?
What is the clinical significance of pre‑ductal versus post‑ductal oxygen saturation measurements in infants with a patent ductus arteriosus?
What is the appropriate management for a 74-year-old male with new‑onset Bell’s palsy?
What is the recommended evaluation and management for a 24‑year‑old patient with no past history of tuberculosis, hypertension, diabetes mellitus, or heart failure who presents with reduced chest wall movement, dullness to percussion, decreased breath sounds, fever, tachycardia, and tachypnea?
What is the appropriate management for a patient with bacterial vaginosis, negative STI testing, who has already been on antibiotics for several days?
Is a posterior circulation stroke reversible?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.